| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.063 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.8 |